US Vaccine Candidate Heads To Widespread Testing In People
A COVID-19 vaccine candidate developed by the US company Moderna and the National Institutes of Health starts its final phase of testing today. It's one of a handful of candidates to reach this stage.
Subscribe to:
Post Comments (Atom)
-
The German cabinet will hold a secret session on Wednesday to discuss safeguard measures regarding the possible participation of China's...
-
Stocks poised for another day of gains Equity markets look to add to the gains from the prior session as investor concerns about the fu...
-
By LIAM STACK from NYT Magazine https://ift.tt/2FNPp6k
No comments:
Post a Comment